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compared to other trypsin-like serine proteases.
Conclusions: Building on evidence that matriptase acts as a novel initiator
of cartilage collagen destruction, these new data show that it can also
potently degrade cartilage proteoglycan by induction of MMPs and
ADAMTS4. We have demonstrated that this breakdown is largely due to
the activity of MMPs. The matriptase inhibitor appears to be potent and
selective towards matriptase and represents a valid start point for drug
development in OA.
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GLYCAN MAPPING AND GALECTIN-1 EXPRESSION IN OSTEOARTHRITIC
CARTILAGE
S. Toegel 1, D. Bieder 1, S.M. Walzer 1, M. Lohr 2, H. Kaltner 2, H.-J. Gabius 2,
R. Windhager 1. 1Med. Univ. of Vienna, Vienna, Austria; 2 Ludwig-
Maximilians-Univ., Munich, Germany
Purpose: The glycosylation of cells and tissues is a complex process that
contributes to the adhesion capacity of cells and potentially affects cellular
signal transduction or the onset of apoptosis. In this context, the glycan-
encoded information may be translated into a biological effect by endog-
enous lectins such as galectins.
Despite the signiﬁcance of glycoproteins for the maintainance of cartilage
functionality, the potential implications of the chondrocyte glycophenotype
in the pathophysiology of osteoarthritis (OA) remain largely unknown.
The present study aimed to assess the glycan proﬁle and the expression of
Galectin-1 in human OA cartilage and to determine the effect of Galectin-1
on primary chondrocytes in vitro.
Methods: Cartilage specimens were collected from OA patients under-
going knee replacement surgery (n¼10) prior to processing for immuno-
histochemistry. Following staining with safranin-O, the grade of cartilage
degeneration was deﬁned in 90 histological sections using the Mankin
degeneration score. Using a panel of 11 plant lectins, common constituents
of natural glycans, serving as ligands for endogenous lectins (galectins),
were attributed to the tissue sections. Histochemical analysis of Galectin-1
binding sites was accomplished using biotinylated human Galectin-1. The
number of Galectin-1 positive chondrocytes was evaluated in cartilage
specimens as a function of the degeneration score. The biological effect of
Galectin-1 on isolated primary human chondrocytes was determined
using RT-qPCR and ELISA assays.
Results: The intensity of plant lectin staining was subject to the grade of
cartilage degeneration. Cartilage tissues with a high Mankin score were
characterized by strong plant lectin staining indicating the expression of
functional glycan epitopes in degenerated cartilage. Moreover, binding
sites for Galectin-1 were detected in OA cartilage. Importantly, a signiﬁcant
correlation was revealed between the number of Galectin-1 positive
chondrocytes and the degeneration score (r¼0.71). RT-qPCR and ELISA
assays demonstrated that Galectin-1 strongly upregulated Interleukin-1ß
as well as Matrix metalloproteinase-3 and -13 mRNA and protein levels in
cultured chondrocytes.
Conclusions: Viewing OA from a glycobiological perspective, we found that
the expression of glycan epitopes was signiﬁcantly more pronounced in
highly degenerated OA cartilage as compared to intact cartilage. Of note, the
expression of Galectin-1 by chondrocytes correlated with the cartilage
degeneration score, indicating the potential translation of the sugar code
into biological effects. In this context, we demonstrated Galectin-1 binding
sites in OA cartilage and showed that Galectin-1 induced catabolic processes
in chondrocytes in vitro. In summary, this study suggests a role for altered
glycan proﬁles and Galectin-1 expression in OA disease progression.
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CARTILAGE DAMAGE IN VIVO AND IN VITRO REGULATES MOLECULES
THAT DRIVE PAIN IN MURINE OSTEOARTHRITIS
A. Chanalaris 1, C.B. Knights 2, K.W. Chong 1, C. Driscoll 1, C. Gentry 2,
S. Bevan 2, T.L. Vincent 1. 1Kennedy Inst. of Rheumatology, London, United
Kingdom; 2Wolfson Ctr. for Age-Related Diseases, London, United Kingdom
Purpose: Pain is the main symptom of osteoarthritis (OA), but it is
currently unknownwhich tissues give rise to pain and what drives it in OA.Our previous studies in painful behaviour in mice following surgical
induction of OA revealed that mice develop pain at around 8 weeks post-
surgery. At this time there ismoderate cartilage damage, but little synovitis
in the joint. The aim of this study was to identify which pain pathways are
activated in painful OA joints, in which tissues are these pathways acti-
vated, and what is driving them.
Methods: Partial meniscectomy or sham operation was performed in 10
week old female C57B6 mice. Pain assessments were performed weekly.
RNA was isolated from whole knee joints, or from micro-dissected tissues
(articular cartilage, meniscus and tibial epiphysis). For cartilage injury
responses in vitro, RNA was isolated from hip epiphyses of 5 week old
mice, at 0 and 4h post-explantation. RT-PCR was performed using
Taqman Low Density Arrays for 67 genes that are involved in inﬂam-
mation and pain.
Results: Pain developed 8 weeks after partial menisectomy. Bradykinin
receptors (BDKRB1 and 2), protachykinin (TAC1), tachykinin receptor 1
(TACR1), nerve growth factor (NGF), neuropeptide Y (NPY) and CCL21were
the only genes upregulated in the whole joint compared to sham operated
joints from the panel of 67 genes. When we examined the microdissected
tissues we found that the same genes, apart from BDKRB2 and NPY, were
upregulated in cartilage. BDKRB2 was upregulated in the epiphysis. NPY
was not regulated in anyof themicrodissected tissues. To establishwhether
cartilage injury per se could induce these same genes, we looked at the
regulation of pain related genes in explanted murine hips. NGF, BDKRB1/2,
TAC1 and NPY were strongly regulated upon cartilage injury in vitro.
Conclusions: This study has revealed a number of important observations:
 A select group of pain mediators and receptors are regulated in
the joint when meniscectomised mice develop pain.
 Expression of these mediators and receptors is occurring in
a non-inﬂamed joint, and is not associated with expression of
other inﬂammatory molecules.
 The majority of these pain mediators and receptors are
expressed in the damaged cartilage in vivo and regulated by
cartilage injury in vitro.227
THE MOLECULAR RESPONSE TO ACUTE JOINT DESTABILISATION IS
ALTERED IN FEMALE COMPARED TO MALE MICE.
C. Driscoll, A. Burleigh, A. Chanalaris, J. Saklatvala, T.L. Vincent. Kennedy
Inst. of Rheumatology, London, United Kingdom
Purpose: It is well established that gender is an independent risk factor for
the development of osteoarthritis (OA). Human epidemiological studies
have highlighted the increased incidence of disease in women after the age
of 50 years. This postmenopausal increase in OA has been attributed to
changes in sex hormones, and has led to the suggestion that estrogen has
chondro-protective effects. This is supported by the observation that the
disease severity of surgically induced OA in female pre-menopausal mice is
signiﬁcantly lower than in males, and that in female mice it is increased
following oophorectomy. The effect of sex hormones onOA severity could be
at the level of the joint tissues themselves, or could be indirect by affecting
other factors such as levels of physical activity. The aimof this project was to
investigate the mechanisms by which gender affects severity of OA.
Methods: OAwas induced in 10 week old male and female C57B/6 mice by
destabilisation of the medial meniscus (DMM). OA was assessed by
histological assessment of the joints at 4, 8 and 12 weeks post DMM or
sham surgery. Activity levels in mice were assessed using LABORAS
(Laboratory Animal Behaviour Observation Registration and Analysis
System) which is able to distinguish different types of activity (running,
eating, climbing, resting). Pain assessments were performed using The
Linton incapacitance tester (which measures differential weight born
through the operated compared to non-operated joints). RNA was
extracted frommouse knee joints for RT-PCR analysis 6h following surgery
to determine whether gender inﬂuences the molecular response to acute
joint destabilisation.
Results: Histological analysis conﬁrmed previous studies demonstrating
an increase in severity of OA in male compared to female mice at 4, 8 and
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increased activity. In fact LABORAS revealed that female mice (at 2 weeks
post-surgery) spent more time running and climbing compared to their
male counterparts. Female mice developed painful behaviour at a similar
time post-surgery (12-14 weeks) to males, despite being at an earlier stage
of cartilage damage. We have recently described the molecular response to
acute joint destabilisation which reveals the mechanosensitive induction
of a number of inﬂammatory response genes and potential repair factors.
When we studied this panel of 47 genes in male and female joints we
found that some responded identically in male and female joints, whilst
other were more highly expressed in the female joints. Speciﬁcally, there
was no difference in the levels of Adamts5, IL1b or Mmp13, but TIMP1 (the
metalloproteinase inhibitor), inhibin (a TGFb family member), versican
and Mmp3 were signiﬁcantly higher in female joints.
Conclusions: Pre-menopausal female mice have signiﬁcantly less severe
OA compared to males, and this cannot be attributed to higher levels of
activity in male mice. Nor is it related to increased painful behaviour as
female mice have similar levels as male mice but with less cartilage
damage. The response to acute joint destabilisation reveals an increase in
predominantly matrix, repair and anti-inﬂammatory genes in female mice
compared to males, thereby suggesting that female mice may mount
a more anti-inﬂammatory/repair response compared to males.
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SUSTAINED DELIVERY OF IL-1RA FROM PLGA MICROSPHERES
ATTENUATES IL-1b MEDIATED INFLAMMATION IN A CARTILAGE
TISSUE ANALOG
D.J. Gorth, W. Strutz, B. Mohanraj, R.L. Mauck, L.J. Smith, G.R. Dodge. Univ.
of Pennsylvania, Philadelphia, PA, USA
Purpose: In healthy articular cartilage, chondrocytes maintain equilibrium
between degradation and synthesis. Injury, aging, and misuse can disturb
this balance triggering degeneration characteristic of osteoarthritis.
Current therapeutic options are limited. This study evaluated a novel
therapeutic that targets a cause of degradation, inﬂammatory cytokines
using a cartilage tissue analog (CTA). Using IL-1ra delivered by poly(lactic-
co-glycolic acid) (PLGA) microspheres (MS) our therapeutic approach
mitigates IL-1b’s deleterious effects on cartilage.
Methods: Microsphere Fabrication and Release Kinetics: PLGA MS were
fabricated using the water-oil-water double emulsion technique. Release
kinetics were determined in PBS under agitation at 37C. Over the course
of 5 weeks, supernatant was collected and IL-1ra content was quantiﬁed
using the bicinchoninic acid assay. Cell Isolation and CTA Fabrication:
Chondrocytes were isolated from juvenile bovine knees. Articular cartilage
was removed and minced, and digested with collagenase. The cell
suspension was ﬁltered and washed. Cells were seeded 1x107 cells/well
into a 96-well plate onto poly (2-hydroxyethyl methacrylate to maintain
their cartilage phenotype then cultured for 10 weeks. Cell Treatment: The
treatment groups were: untreated, 10 ng/ml IL-1b, and 10 ng/ml IL-1b +
500 mg/ml IL-1ra MS. CTAs were harvested after 3 and 6 days of treatment.
The 6-day treatment group included 60% media changes at 3 days, with
additional doses of IL-1b added to the relevant groups. mRNA Levels: RNA
was isolated from the CTAs via two sequential extractions using TRIZOL-
chloroform (n¼6). Reverse transcription was performed on 1 mg of RNA in
a 20 ml volume. Quantitative PCRwas performed to determinemRNA levels
of collagen II, aggrecan, COMP, IL-6, iNOS and ADAMTS4, and normalized to
GAPDH. Nitrite Concentration: Nitrite levels in the mediumwere measured
using the Griess assay. Statistics: Differences between treatment groups
were established using ANOVAs with post-hoc Tukey's tests; p<0.05 was
considered signiﬁcant.
Results: IL-1ra was released from the PLGAMS over the course of 5 weeks.
After a burst release in the ﬁrst hour (20.24.4ng per mg of MS), IL-1ra
release leveled to a linear release from day 2 to day 35 of 0.2 ng per mg of
MS per day (r2¼0.99). DeliveringMS to IL-1b treated CTAs inhibited IL-1b’s
effect. While IL-1b caused a large increase in nitrite concentration simul-
taneous IL-1raMS delivery reduced the increase. After both 3 and 6 days,
CTAs treated with IL-1b had signiﬁcantly higher iNOS, ADAMTS4, and IL-6
mRNA levels compared to untreated CTAs. IL-1b treated CTAs had a cor-
responding decrease in themRNA levels of collagen II, aggrecan and COMP.CTAs treated with both IL-1b and IL-1ra MS had no signiﬁcant differences
compared to the untreated.
ĂConclusions: In this study we showed for the ﬁrst time that sustained
IL1-ra released from PLGA microspheres can effectively inhibit IL-1b
mediated inﬂammation in cartilage. Our results suggest that this inhibition
was effective beyond the initial burst release, extending up to 6 days in the
presence of repeated doses of IL-1b. This study provides the foundation for
developing a novel treatment for osteoarthritis.
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FATTY ACIDS MODULATE DESTRUCTIVE AND INFLAMMATORY
PROCESSES IN OSTEOARTHRITIC CARTILAGE
M. Siawash. Erasmus Med. Ctr., Rotterdam, Netherlands
Purpose: Onset and progression of osteoarthritis (OA) are associated
with obesity. Since not only knee OA but also hand OA is associated with
obesity, it is plausible that next to increased joint loading, systemic
metabolic alterations such as adipose-related inﬂammation might
explain this association. In addition, obesity is correlated with altered
fatty acid proﬁles in serum. Recent studies indicate that n-3 poly
unsaturated fatty acids (PUFA's) such as eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) decrease inﬂammation and n-6 PUFA
arachidonic acid (AA) increases inﬂammation in OA joints. In this study
we aim to investigate whether other fatty acids known to be present in
the knee joint such as linoleic acid (n-6), oleic acid (n-9), and palmitic
acid (saturated) are also able to inﬂuence cartilage and thereby
contribute to processes seen in OA.
Methods: Cartilage was obtained from OA patients undergoing total knee
arthroplasty and either cultured as explants (3 donors) or as chon-
drocytes (2 donors) isolated from the cartilage (passage 3). All were
cultured in DMEM low glucose and 1% ITS with or without 10 ng/ml TNFa
as a pro-inﬂammatory stimulus and in absence or presence of DHA,
linoleic acid, oleic acid or palmitic acid. Concentrations were determined
using mass spectrometry. Analysis of cell cultures included quantiﬁcation
of intracellular lipid deposition using Oil-red-O, lactate hydrogenase
(LDH)-assay for cytotoxicity and gene expression for cyclooxygenase 2
(COX2), matrix metalloproteinase (MMP) 1, 3 and 13 and A Disintegrin
and Metalloproteinase with ThromboSpondin motifs (ADAMTS) 4. Carti-
lage explants were analysed for glycosaminoglycan (GAG) release and
nitric oxide (NO) production. Independent sample T-test was used for all
data analysis.
Results: Culturing chondrocytes in the presence of the fatty acids resulted
in an increase of intracellular lipid deposition as determined with Oil-red-
O staining. This effect was independent of TNFa presence in the culture
